Found: 9
Select item for more details and to access through your institution.
Bendamustine with or without rituximab for the treatment of heavily pretreated non-Hodgkin's lymphoma patients.
- Published in:
- Annals of Hematology, 2012, v. 91, n. 7, p. 1013, doi. 10.1007/s00277-012-1422-5
- By:
- Publication type:
- Article
Consensus for Flow Cytometry Clinical Report on Multiple Myeloma: A Multicenter Harmonization Process Merging Laboratory Experience and Clinical Needs.
- Published in:
- Cancers, 2023, v. 15, n. 7, p. 2060, doi. 10.3390/cancers15072060
- By:
- Publication type:
- Article
Conservative treatment for patients over 80 years with acute myelogenous leukemia.
- Published in:
- American Journal of Hematology, 2002, v. 71, n. 4, p. 256, doi. 10.1002/ajh.10235
- By:
- Publication type:
- Article
Prognostic factors associated with progression of smoldering multiple myeloma to symptomatic form.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 22, p. 5544, doi. 10.1002/cncr.27657
- By:
- Publication type:
- Article
A Multicenter, Randomized Clinical Trial Comparing Zoledronic Acid Versus Observation in Patients With Asymptomatic Myeloma.
- Published in:
- Cancer (0008543X), 2008, v. 113, n. 7, p. 1588, doi. 10.1 002/cncr.23783
- By:
- Publication type:
- Article
Arterial and venous thrombosis in patients with monoclonal gammopathy of undetermined significance: incidence and risk factors in a cohort of 1491 patients.
- Published in:
- British Journal of Haematology, 2013, v. 160, n. 5, p. 673, doi. 10.1111/bjh.12168
- By:
- Publication type:
- Article
Bendamustine with or without rituximab in the treatment of relapsed chronic lymphocytic leukaemia: an Italian retrospective study.
- Published in:
- British Journal of Haematology, 2011, v. 153, n. 3, p. 351, doi. 10.1111/j.1365-2141.2011.08597.x
- By:
- Publication type:
- Article
Intracardiac Thrombus in a Patient with Autoimmune Hemolytic Anemia Leading to a Diagnosis of Antiphospholipid Syndrome.
- Published in:
- Acta Haematologica, 2002, v. 107, n. 3, p. 170, doi. 10.1159/000057635
- By:
- Publication type:
- Article
Daratumumab combined with dexamethasone and lenalidomide or bortezomib in relapsed/refractory multiple myeloma (RRMM) patients: Report from the multiple myeloma GIMEMA Lazio group.
- Published in:
- EJHaem, 2022, v. 3, n. 1, p. 121, doi. 10.1002/jha2.359
- By:
- Publication type:
- Article